Insider filing · ELVN
Rahul D. Ballal
Director
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 61 filings in 24 months
ticker →
Rahul D. Ballal sold $294K of Enliven Therapeutics (ELVN)
Executed Oct 8 2024, disclosed Oct 10 2024, 2 days later.
Value, as filed
$294K
10,420 sh × $28.17
Executed
Oct 8 2024
the trade date, as filed
Disclosed
Oct 10 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RBRahul D. Ballal (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Agios Pharmaceuticals, Inc. (AGIO). The largest single filing was $1.0M of AGIO (18,500 sh across 4 lots, as filed), executed Nov 7 2024.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→